TCL Archive News Analysis: Industry’s Accelerated Recovery Initiative May Push Manufacturers Toward Collusion October 5, 2012
TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983
TCL Archive New Year Sees Growing Attacks On Cancer Program; Critics Repeat Untrue Charges, OMB Continues January 3, 1975
